Scroll for more

Global leader in the development and application of AI for scientific innovation

One of the world's largest private AI companies

Changing the way discovery happens

Despite the explosive growth of data, scientific discovery has not changed for 50 years.  It is impossible for humans alone to process all the world’s available scientific data and literature.  Consequently, only a tiny fraction of scientific knowledge is accessible, decipherable and usable at any one point in time to a given scientist.

Augmenting human intelligence

BenevolentAI uses proprietary AI and machine learning technology, together with its own unique team of pioneering scientists, to look deeply into vast scientific research data sets - rapidly forming and qualifying hypotheses, generating new insights and enabling hitherto impossible scientific intuition and innovation at previously unimaginable scale.  

Discovering new medicines

We began with a focus on bioscience – increasing the understanding of human biology by ingesting the entire compendium of information on human health and biological systems.  We are applying this knowledge to pharmaceutical development to bring better medicines to patients faster.

Our benevolent world

Find out what’s been going on in our benevolent world below, from our latest news, events and breaking research developments.

Jun 21, 2018 blog - benevolentai

BenevolentAI Awarded Technology Pioneer Status by World Economic Forum

Every year, the World Economic Forum welcomes leading early-stage technology companies from around the world into its Technology Pioneer’s community. In its own words, these companies are “poised to have a significant impact on business and society”. Today we are delighted and humbled to be named as one such Technology Pioneer.

View blog

Awards and accreditations

We are hiring

Come and work for an inventive company applying AI to some of the biggest problems in science and society.

Join our team

Contact us

General enquiries

[email protected]
+44 20 3096 0720


[email protected]
+44 20 7632 3880


[email protected]
+44 20 3096 0720

Data Protection

[email protected]
+44 20 3874 3134



40 Churchway, London, NW1 1LW
+44 (0)20 3096 0720


Minerva Building, Babraham Hall, Cambridge, CB22 3AT
+44 (0)1223 497 300

New York

81 Prospect St, Brooklyn, New York 11201